↓ Skip to main content

Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia

Overview of attention for article published in BMC Neuroscience, March 2015
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter
2 X users
patent
1 patent

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
99 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia
Published in
BMC Neuroscience, March 2015
DOI 10.1186/s12868-015-0149-3
Pubmed ID
Authors

Ludmyla Kandratavicius, Priscila Alves Balista, Daniele Cristina Wolf, Joao Abrao, Paulo Roberto Evora, Alfredo Jose Rodrigues, Cristiano Chaves, Joao Paulo Maia-de-Oliveira, Joao Pereira Leite, Serdar Murat Dursun, Glen Bryan Baker, Francisco Silveira Guimaraes, Jaime Eduardo Cecilio Hallak

Abstract

Better treatments for schizophrenia are urgently needed. The therapeutic use of the nitric oxide (NO)-donor sodium nitroprusside (SNP) in patients with schizophrenia has shown promising results. The role of NO in schizophrenia is still unclear, and NO modulation is unexplored in ketamine (KET) animal models to date. In the present study, we compared the behavioral effects of pre- and post-treatment with SNP, glyceryl trinitrate (GTN), and methylene blue (MB) in the acute KET animal model of schizophrenia. The present study was designed to test whether acute SNP, GTN, and MB treatment taken after (therapeutic effect) or before (preventive effect) a single KET injection would influence the behavior of rats in the sucrose preference test, object recognition task and open field. The results showed that KET induced cognitive deficits and hyperlocomotion. Long- term memory improvement was seen with the therapeutic GTN and SNP treatment, but not with the preventive one. MB pretreatment resulted in long-term memory recovery. GTN pre-, but not post-treatment, tended to increase vertical and horizontal activity in the KET model. Therapeutic and preventive SNP treatment consistently decreased KET-induced hyperlocomotion. NO donors - especially SNP - are promising new pharmacological candidates in the treatment of schizophrenia. In addition, we showed that the potential impact of NO-related compounds on KET-induced behavioral changes may depend on the temporal window of drug administration.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 99 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 1%
Unknown 98 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 17 17%
Student > Master 12 12%
Student > Doctoral Student 10 10%
Student > Bachelor 10 10%
Researcher 7 7%
Other 14 14%
Unknown 29 29%
Readers by discipline Count As %
Medicine and Dentistry 17 17%
Neuroscience 17 17%
Psychology 9 9%
Biochemistry, Genetics and Molecular Biology 7 7%
Pharmacology, Toxicology and Pharmaceutical Science 6 6%
Other 9 9%
Unknown 34 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 April 2019.
All research outputs
#6,952,277
of 22,800,560 outputs
Outputs from BMC Neuroscience
#337
of 1,244 outputs
Outputs of similar age
#80,010
of 258,815 outputs
Outputs of similar age from BMC Neuroscience
#4
of 18 outputs
Altmetric has tracked 22,800,560 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 1,244 research outputs from this source. They receive a mean Attention Score of 4.3. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 258,815 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.